Viromed Medical AGXTER:VME +2.16%15 Days Payable is 68.26 as of Dec. 2025, which is 31% below its 10-year median of 99.39. GuruFocus rates XTER:VME with a GF Score™ of 15/100. The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Viromed Medical AG ranks better than 70.31% on this metric.
The historical rank and industry rank for Viromed Medical AG's Days Payable or its related term are showing as below:
XTER:VME'
s Days Payable Range Over the Past 10 Years
Min: 83.95 Med: 99.39 Max: 115.59
Current: 115.59
During the past 5 years, Viromed Medical AG's highest Days Payable was 115.59. The lowest was 83.95. And the median was 99.39.
XTER:VME's Days Payable is ranked better than 70.31% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs XTER:VME: 115.59
Viromed Medical AG's Days Payable
declined
from Dec. 2024 (73.10) to Dec. 2025 (68.26).
It may suggest that Viromed Medical AGaccelerated paying its suppliers.
Viromed Medical AG Days Payable Related Terms
Viromed Medical AG Days Payable Historical Data
* Premium members only.
The historical data trend for Viromed Medical AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:VME vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Viromed Medical AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viromed Medical AG Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viromed Medical AG's Days Payable distribution charts can be found below:
* The bar in red indicates where Viromed Medical AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Viromed Medical AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viromed Medical AG (XTER:VME) has a Days Payable of 68.26 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Viromed Medical AG and its competitors. This is 31% below median its historical median of 99.39. Over the past decade, Viromed Medical AG's Days Payable has ranged from 83.95 to 115.59. According to the industry distribution chart, Viromed Medical AG ranks #236 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 29.7%.
Is Viromed Medical AG's Days Payable too high?
Viromed Medical AG's current Days Payable of 68.26 is 31% below median its 10-year median of 99.39. Over the past 10 years, this metric has ranged from a low of 83.95 to a high of 115.59. The Medical Devices & Instruments industry median Days Payable is 68.07. Viromed Medical AG's value of 68.26 is 0.3% above this industry median. Based on the distribution chart, Viromed Medical AG ranks #236 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Viromed Medical AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Viromed Medical AG ranks #236 out of 795 companies for Days Payable. This puts Viromed Medical AG in the upper half of its industry. The industry median Days Payable is 68.07. Viromed Medical AG's value of 68.26 is 0.3% above this benchmark. Historically, Viromed Medical AG's own Days Payable has ranged from 83.95 to 115.59 over the past decade. While the company's 10-year median is 99.39 vs. the industry median of 68.07, Viromed Medical AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viromed Medical AG's current Days Payable of 68.26 is 0.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Viromed Medical AG and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viromed Medical AG's current Days Payable is 68.26, which is 31% below median its own 10-year median of 99.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (XTER:VME) has a current Days Payable of 68.26. The current Days Payable is 68.26, which is 31% below median its 10-year median of 99.39 and 0.3% above the Medical Devices & Instruments industry median of 68.07. Viromed Medical AG's overall GF Score™ is 15/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Viromed Medical AG (XTER:VME), the current Days Payable is 68.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
15GF Score
Get the complete analysis for XTER:VME
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:VME has been successfully added to your 
